Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

Shield Therapeutics revenues boosted by US sales of iron deficiency pills

The pharmaceuticals firm recently joined forced with Pennsylvania-based Viatris to tackle the American market

Birmingham Post

Bayer Snags Ex-Roche Exec Bill Anderson As New CEO; Shares Rocket

Bayer stock surged to an eight-month high Wednesday after the company named former Roche exec Bill Anderson as its new chief executive.

Investors Business Daily

How IBD Stock Of The Day Inspire Medical Systems Won A Breakout

Inspire is Wednesday's IBD Stock Of The Day. The sleep apnea expert reported massive sales growth, leading shares to break out.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Teva Guides To Its First Year Of Growth Since 2017 — But Shares Tumbled On This Caveat

Teva expects 2023 sales to grow for the first time in six years, but the guidance comes with one notable caveat and Teva stock fell.

Investors Business Daily

CVS buys Chicago-based Oak Street Health for $10.6B

Oak Street Health runs primary care centers mostly for lower-to-middle income people with Medicare Advantage plans.

Chicago Sun-Times

Glasgow biopharmaceuticals firm hires new chief executive

University spin-out takes on new leadership as it looks towards international growth

Insider UK

Vertex Stock Topples As Investors Seek Clearer Vision Of Future Despite Huge Profit Beat

Vertex Pharmaceuticals' fourth-quarter sales divided analysts Wednesday as VRTX stock toppled on a lack of near-term catalysts.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Anavex Life Sciences Stock Shows Improved Price Strength Rating

Anavex Life Sciences shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

1 Medical Stock to Get Bullish on Right Now

Medical stock Zoetis (ZTS) has witnessed steady growth despite the market turbulence in the past few months. Moreover, Wall Street analysts expect the stock to soar further. So, considering its robust fundamentals, ZTS might be worth buying now. Keep reading.

StockNews.com

Vertex Pharmaceuticals Battles Back With A Boost To 81 RS Rating

Vertex Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 73 to 81.

Investors Business Daily

Pfizer’s Susan Rienow: from Covid to fighting the ‘silent pandemic’

The pharma giant’s UK chief is adding the company’s voice to scientists’ warnings of the dangers of antibacterial resistance

The Guardian - UK

Nodus Oncology secures £2.4 million investment

Edinburgh-based start-up will now be able to accelerate development of its life sciences technology

Insider UK

Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover

Catalent stock launched higher Monday on a rumor that Danaher could acquire it in a bid to compete with Thermo Fisher Scientific.

Investors Business Daily

Workers resume strike action as union admit dispute could drag on

Unite chiefs say their members are determined to get 'what they are owed' in bonus payments row.

Daily Record

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Want to Get Richer in 2023? Try This Medical Stock

Mckesson Corporation (MCK) delivered better-than-expected earnings for the last quarter and updated its outlook for fiscal 2023. Wall Street analysts expect the stock to rise more than 18% in the near term. Therefore, it could be wise to buy this medical stock now. Read more….

Investors Business Daily

Neurocrine Reports 3,000% Profit Growth, But Shares Unexpectedly Tumble

Neurocrine reported soaring fourth-quarter profit Monday and issued in-line guidance for Ingrezza. But NBIX stock toppled.

The Independent UK

Pharma giant tops new business gender equality index

‘Lead5050 Index provides a comprehensive snapshot of how well employers tackle the gender pay gap’

AAP

ASX drug companies applaud TGA's psychedelic ruling

Shares in Little Green Pharma and Emyria are up by more than 40 per cent as both announce plans to take advantage of Australia's "world-leading" drug decision.

Get all your
news in one place.

100’s of premium titles.
One news app.

Daily Mirror

'Possibly contaminated' eye drops recalled after patient dies of bloodstream infection

A total of 55 patients reported adverse effects after using EzriCare and Delsam Pharma's Artificial Tears, including eye infections, permanent loss of vision, and a death with a bloodstream infection

The Independent UK

‘Thanks Pfizer’: The weird world of shakes, health anxiety and illness online

Eloise Hendy asks psychologists and doctors if the viral wave of vaccine-induced symptoms is real or faked or something else entirely

Pedestrian.tv

MDMA & Psilocybin Can Now Be Prescribed To Treat Certain Mental Health Conditions In Australia

Australia in its progressive drug policy era????? Here for it.

The Guardian - AU

Port Macquarie cleans up after ‘mini-cyclone’ – as it happened

People in NSW town are being urged to stay away from downed power lines. This blog is now closed

Investors Business Daily

BMRN Stock An Example Of Stock Market Character Change

With subsequent follow-through days mounting and stocks refusing to give up ground, this rally is showing it might be for real.

Investors Business Daily

How IBD Stock Of The Day InMode Is Smoothing Out The Wrinkles

InMode is Friday's IBD Stock Of The Day. The company says it's shrugging off recessionary concerns and INMD stock is smoothing out the wrinkles.

Reuters

U.S. FDA says India-made eye drop linked to some infections, blindness and one death

The U.S. Food and Drug Administration (FDA) has warned against using an eye drop made in India that has been linked to the outbreak of a drug-resistant bacteria leading to adverse events in at least 55 patients in the United States including infections, blindness and one death.

1 … 46 47 48 49

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Vertex Pharmaceuticals

Medical Pharmaceuticals

113 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.